IMR Press / CEOG / Volume 47 / Issue 2 / DOI: 10.31083/j.ceog.2020.02.5174
Open Access Original Research
A 10-year retrospective study on prenatal cytogenetic analyses
Show Less
1 Prenatal Diagnosis Center, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen City, Fujian Province, P.R. China
*Correspondence: zhangjian983@xmu.edu.cn (JIAN ZHANG)
Clin. Exp. Obstet. Gynecol. 2020, 47(2), 248–252; https://doi.org/10.31083/j.ceog.2020.02.5174
Published: 15 April 2020
Copyright: © 2020 Wang et al. Published by IMR Press.
This is an open access article under the CC BY-NC 4.0 license (https://creativecommons.org/licenses/by-nc/4.0/).
Abstract

Objective: To analyze the indications and results of prenatal cytogenetic screening in patients from a specialized center in Xiamen City, China, to provide a reference database for prenatal diagnosis. Materials and Methods: This retrospective, observational study included 7,400 pregnant women who underwent chorionic villous sampling (CVS), amniocentesis or cordocentesis at the Women and Children's Hospital, School of Medicine, Xiamen University, China, over a 10-year period (2008-2018). Clinical data and the results of the cytogenetic analysis were assessed. Results: Fetal chromosomal aberrations were observed in 335 of 7, 400 (4.5%) cases, with trisomy 21 the most common aberration (87/335, 26%). A high risk on maternal serum screening was the indication for cytogenetic analysis in 36 of the 87 fetuses with trisomy 21 (41.4%). Abnormal fetal ultrasonographic findings were the clinical indication for cytogenetic testing in more than half of fetuses with abnormal karyotypes (181/335, 54%). Conclusions: Prenatal cytogenetic analysis is useful for the prenatal diagnosis of birth defects in Xiamen City, and may prevent termination of potentially healthy fetuses.

Keywords
Aneuploidy
Cytogenetics
Karyotype analysis
Prenatal diagnosis
Share
Back to top